While there may not be a simple answer, the goal of this resource is to fuel the conversations that drive greater access for all.
Accessible medicines are a top public health priority and a human right. The reality is, however, that an estimated 2 billion people worldwide still lack reliable access to essential medicines.
As one of the leading U.S.-based biopharmaceutical companies, Amneal was founded to reimagine what’s possible to make medicine accessible for all. Over time, we’ve learned that access is complex and nuanced—yet it’s often either oversimplified or overcomplicated.
This platform is designed to make access clearer. Through data, case studies, and transparent explanations, we break down how supply chains, coverage decisions, patient support, and scientific innovation all work together. By creating a shared resource for policymakers, providers, partners, and patients, we aim to foster conversations that align the healthcare ecosystem around what truly drives access.
Affordability is top of mind for many Americans and is one of the most important factors in accessing essential medicines. But affordability alone isn’t enough. Medicines must also be available, understood, and effective. We explore each of these factors in depth.
We also highlight how access shapes treatment across a range of conditions and patient communities we are committed to, including Parkinson’s disease, migraine and cluster headaches, and cancer.
We are here to help people live better lives, and we recognize that too many still face real challenges when navigating healthcare. Throughout this experience, we invite you to share your perspective so we can continue learning and advancing access to essential medicines—together.
Corporate
India